A Study of LN-144 in People With Metastatic Melanoma to the Brain
Clinical trial NCT05640193 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05640193
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-25
- Primary completion
- 2026-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.